Source:http://linkedlifedata.com/resource/pubmed/id/17697160
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-8-16
|
pubmed:abstractText |
Structural remodelling of left ventricle is a common feature in the progression of congestive heart failure (CHF). Matrix metalloproteinases (MMPs) have been directly implicated as they degrade extracellular proteins. To test the hypothesis that MMP-and its inhibitor, tissue type inhibitor of matrix metalloproteinases (TIMP-1), could be related to functional status and prognosis in CHF, we examined the relationship of MMP-1 and TIMP-1 to peak oxygen consumption (VO2) and peak minute ventilation/carbon dioxide production relationship (VE/VCO2), and assessed their prognostic value.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0954-6820
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
262
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
385-92
|
pubmed:dateRevised |
2009-1-7
|
pubmed:meshHeading |
pubmed-meshheading:17697160-Adult,
pubmed-meshheading:17697160-Aged,
pubmed-meshheading:17697160-Biological Markers,
pubmed-meshheading:17697160-Female,
pubmed-meshheading:17697160-Heart Failure,
pubmed-meshheading:17697160-Humans,
pubmed-meshheading:17697160-Male,
pubmed-meshheading:17697160-Metalloendopeptidases,
pubmed-meshheading:17697160-Middle Aged,
pubmed-meshheading:17697160-Prognosis,
pubmed-meshheading:17697160-Tissue Inhibitor of Metalloproteinase-1
|
pubmed:year |
2007
|
pubmed:articleTitle |
Matrix metalloproteinase-1 and its inhibitor, TIMP-1, in systolic heart failure: relation to functional data and prognosis.
|
pubmed:affiliation |
Cardiology Department, University General Hospital of Elche, Elche, Spain.
|
pubmed:publicationType |
Journal Article
|